Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Issuers confirmation

The arranger should obtain a comfort letter from the auditors to the issuer confirming that all financial information presented in the offering circular has been correctly extracted from the audited financial statements and that there have been no adverse changes in specified financial items since the last financial year end, in the case of balance sheet items, or when compared with the corresponding period in the last financial year, in the case of profit and loss account items. [Pg.900]

Test Account Setup and Approval. The account application is reviewed by the FDA ESG Administrator. The Administrator verifies that a letter of nonrepudiation agreement is on file, that the digital certificate conforms to the X.509 version 3 standard, and that all data fields in the Issuer and Subject fields are completed (see Appendix A, Digital Certificates for more information). The Administrator will also communicate with the Transaction Partner to confirm the application information. If these conditions are met, a test account is set up, and connections to the FDA ESG test system are established before the submitting organization is approved as a Transaction Partner. [Pg.13]

Emerging market spread volatilities are shown in Exhibit 23.10. The spread risk of Latin American obligors tend to be above average, currently largest for Argentinean and Brazilian markets that have a spread risk comparable to a B to CCC rated euro corporate. The risk of Asian issuers is on the other hand below average and comparable to the interest rate observed in developed markets. We clearly observe a wide spectrum of risk characteristics that confirms the need to build a separate factor for each market. [Pg.738]

The auditor s comfort letter confirms that the financial statements included in the offering circular are accurate and that there has been no material change in the financial situation of the issuer since the latest audited financial statements. [Pg.898]

The trustee s role in this process is to ensure that the issuer complies with notice provisions for bondholder meetings, conduct the bondholders meeting itself, certify/confirm the results of the meeting and resolutions and publish notice of the results of each meeting. At the beginning of the process and prior to the notices and resolutions being published, the trustee and its counsel will typically review and comment upon the proposed amendments and notice materials. The trustee s main concern is that the proposed amendments and notices are consistent with the spirit and letter of the issuance documentation and not prejudicial to the bondholders. However, this process also provides the issuer the opportunity to benefit from the trustee s experience in gauging how the bondholders will receive the amendments. [Pg.941]

When the work is complete all copies of the permit should be returned to the issuing point. The permit-issuer should then inspect the worksite to confirm that the work has been completed as intended and that the worksite has been left in a safe and tidy condition, that all blinds have been removed, and that there are no other open permits that apply to the same equipment. Only then should the permit-issuer sign off the permit. [Pg.31]


See other pages where Issuers confirmation is mentioned: [Pg.898]    [Pg.910]    [Pg.910]    [Pg.919]    [Pg.81]   
See also in sourсe #XX -- [ Pg.910 ]




SEARCH



CONFIRM

Confirmation

Issuers

© 2024 chempedia.info